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 Oropharyngeal candidiasis (OPC;  “ thrush ” ) is 
an AIDS-defi ning illness caused mainly by the 
commensal fungus  Candida albicans and related 
species ( 1 ).  C. albicans also causes vaginal candi-
diasis, onychomycosis, and disseminated candi-
diasis. Disseminated candidiasis typically occurs 
as a nosocomial infection in neutropenic pa-
tients and has a 40% mortality rate ( 2 ). Inter-
estingly, host defense mechanisms against  C. 
albicans vary by anatomical site, as HIV-infected 
patients are primarily susceptible to oropharyn-
geal, but not vaginal or disseminated, candidia-
sis ( 1, 3, 4 ). Thus, CD4 + T cells play a more 
central role in OPC compared with other 
forms of candidiasis, but the mechanisms by 
which this occurs remain poorly understood. 
 Recently, a new CD4 + T eff ector cell was 
discovered that was distinct in lineage and cy-
tokine profi le from classical Th1 and Th2 pop-
ulations. Termed  “ Th17, ” these cells secrete 
IL-17 (IL-17A) and IL-17F, IL-21, and IL-22 
( 5 ). Whereas Th1 cells develop in response to 
IL-12 (a heterodimeric cytokine composed of 
IL-12p35 and IL-12p40 subunits), Th17 cells 
are induced to diff erentiate by a combination 
of TGF-  , IL-6, IL-1, and IL-21. The IL-12 
family cytokine IL-23, comprised of IL-12p40 
and the unique partner IL-23p19, is essential 
for Th17 cell expansion and function. Despite 
a common subunit, IL-12 and IL-23 have di-
chotomous functions in vivo ( 5, 6 ). 
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 The commensal fungus  Candida albicans causes oropharyngeal candidiasis (OPC; thrush) in 
settings of immunodefi ciency. Although disseminated, vaginal, and oral candidiasis are all 
caused by  C. albicans species, host defense against  C. albicans varies by anatomical loca-
tion. T helper 1 (Th1) cells have long been implicated in defense against candidiasis, 
whereas the role of Th17 cells remains controversial. IL-17 mediates infl ammatory pathol-
ogy in a gastric model of mucosal candidiasis, but is host protective in disseminated dis-
ease. Here, we directly compared Th1 and Th17 function in a model of OPC. Th17-defi cient 
(IL-23p19   /   ) and IL-17R – defi cient (IL-17RA   /   ) mice experienced severe OPC, whereas 
Th1-defi cient (IL-12p35   /   ) mice showed low fungal burdens and no overt disease. Neu-
trophil recruitment was impaired in IL-23p19   /   and IL-17RA   /   , but not IL-12   /   , mice, 
and TCR-   cells were more important than TCR-   cells. Surprisingly, mice defi cient in 
the Th17 cytokine IL-22 were only mildly susceptible to OPC, indicating that IL-17 rather 
than IL-22 is vital in defense against oral candidiasis. Gene profi ling of oral mucosal tissue 
showed strong induction of Th17 signature genes, including CXC chemokines and   defen-
sin-3. Saliva from Th17-defi cient, but not Th1-defi cient, mice exhibited reduced candida-
cidal activity. Thus, the Th17 lineage, acting largely through IL-17, confers the dominant 
response to oral candidiasis through neutrophils and antimicrobial factors. 
© 2009 Conti et al. This article is distributed under the terms of an Attribu-
tion–Noncommercial–Share Alike–No Mirror Sites license for the fi rst six months 
after the publication date (see http://www.jem.org/misc/terms.shtml). After six 
months it is available under a Creative Commons License (Attribution–Noncom-
mercial–Share Alike 3.0 Unported license, as described at http://creativecommons
.org/licenses/by-nc-sa/3.0/).
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Saliva from IL-17RA KO and IL-23 KO mice showed a reduced 
capacity to kill  C. albicans in vitro, which correlated with re-
duced levels of BD3 in the oral mucosa. Thus, immunity to 
OPC appears to be dominantly regulated by IL-17 signaling 
rather than Th1 cells. 
 RESULTS 
 Th17-defi cient and IL-17 receptor – defi cient mice 
are susceptible to oral candidiasis 
 To dissect T cell responses during OPC, we used a quantita-
tive mouse model of OPC ( Fig. 1 A ) in which mice were in-
fected sublingually with 2  × 10 7  C. albicans blastospores/ml. 
The extent of candidiasis was evaluated 5 d later by tissue 
fungal burden ( Fig. 1 B ) and histology ( Fig. 1, C – E ). None 
of the mice exhibited detectable carriage of oral  C. albicans 
based on an oral swab taken before the fi rst infection (un-
published data). Similar to immunocompetent humans, WT 
mice infected with  C. albicans are almost completely resistant 
to infection, with an extremely low fungal burden 5 d after 
inoculation ( Fig. 1, B – D ). Inoculation of  C. albicans into 
immunocompetent WT mice was associated with a strong 
neutrophilic infi ltration into the oral cavity, in the epithelial, 
basal, and muscular layers of the tongue ( Fig. 1 D ). When 
WT mice were immunosuppressed with cortisone acetate, a 
mean of 1.5  × 10 6 CFU/g (geometric mean of 6.4  × 10 5 ) was 
recovered from tongue ( n = 16;  Fig. 1 B ; see also  Fig. 2 A ), 
which is consistent with prior fi ndings ( 25 ). These mice lost 
considerable body weight ( Fig. 1 F ) and exhibited fungal 
patches covering the dorsal layer of the tongue, palate, and 
buccal mucosa ( Fig. 1 G ). Microscopic analysis indicated that 
yeast invaded the superfi cial epithelial layer of the mucosa, 
destroying the papillae and the overall architecture of the ke-
ratinized superfi cial epithelium. There was extensive prolif-
eration of the basal germinal layer, which is indicative of 
ongoing tissue repair. Although some neutrophils and eosin-
ophils were found at infected sites, this was substantially re-
duced compared with WT mice ( Fig. 1 D vs.  Fig. 1 E ). Both 
hyphal and blastoconidial forms of  C. albicans were present 
( Fig. 1 E ). Thus, this model faithfully reproduces key clinical 
features of human OPC ( 25 ). 
 To compare Th1 and Th17 cells in OPC directly, IL-
12p35 – and IL-23p19 – defi cient mice (hereafter, IL-12 KO and 
IL-23 KO ) were infected with  C. albicans . IL-23 KO mice 
showed a fungal burden of 2.6  × 10 4 CFU/g, which was less 
than cortisone-treated WT mice, but nonetheless indicated 
considerable susceptibility to OPC ( Fig. 2 A ). In contrast, 
IL-12 KO mice (1.4  × 10 3 CFU/g) were   450-fold less sus-
ceptible than cortisone-treated WT mice and   20-fold less 
susceptible than IL-23 KO mice, indicating that IL-23 is far 
more important for mediating host defense against OPC than 
IL-12. Weight loss values were consistent with recovery of 
 C. albicans cells from tongue, as IL-23 KO mice showed con-
tinuous weight loss, whereas IL-12 KO mice showed transient 
weight loss at day 2, but recovered by day 5 ( Fig. 2 B ). Al-
though characteristic  C. albicans lesions were readily visible 
on the palates and tongues of IL-23 KO mice, no fungal lesions 
 Recent studies have revealed an essential role for IL-17 
and other Th17 cytokines in host defense at mucosal surfaces 
such as lung and gut, mediated by induction of prototypical 
innate immune genes including neutrophil-activating factors 
(CXC chemokines, G-CSF, and ICAM-1), antimicrobial 
peptides (defensins, mucins, and S100 proteins), and acute 
phase proteins (IL-6, lipocalin 2, CRP, and SAA) ( 7 – 10 ). 
Consistent with a mucosal function, Th17 cells express the 
CCR6 and CCR4 receptors, which facilitate targeting to 
mucosal areas ( 11 – 13 ). The oral cavity has many features that 
distinguish it from other mucosal regions, such as saliva and 
unique microbiota ( 14 ). We recently showed that IL-17 plays 
a host-protective role in preventing periodontal bone loss af-
ter infection with a human periodontal pathogen through 
activation of neutrophils ( 15, 16 ). However, the role of IL-
17 and Th17 cells in coordinating host defense in the oral 
mucosa is largely undefi ned. 
 Accumulating evidence implicates IL-17 and Th17 cells 
in host defense against fungi, but no prior studies have exam-
ined these cells in OPC. IL-17 receptor – defi cient (IL-17RA KO ) 
mice are susceptible to disseminated  C. albicans through regu-
lation of neutrophils, particularly via CXC chemokines ( 17 ). 
The pattern recognition receptor dectin-1 binds to   -glucan 
components of yeast cell walls and was reported to drive a 
protective Th17 response in models of disseminated candidi-
asis ( 18, 19 ). In humans, resident memory T cells specifi c for 
 C. albicans are primarily of the Th17 subset ( 11, 20 ). IL-17 
also contributes to host defense against other fungi, including 
 Pneumocystis carinii ( 21 ). Conversely, in mouse models of fun-
gal gastric candidiasis or aspergillosis, IL-17 and IL-23 have 
been reported to play a counterproductive role by amplifying 
infl ammatory pathology ( 22 ). 
 It has long been believed that immunity to OPC is medi-
ated by both neutrophils and Th1 cells ( 2 ). Although neutro-
phils are classically considered part of the innate immune 
response, IL-17 is a critical regulator of neutrophils through 
CXC chemokines and granulopoietic cytokines ( 23 ). IL-
12p40 KO mice are defi cient in Th1 cells and are susceptible to 
OPC ( 24 ); however, IFN-  KO mice also have an impaired 
Th1 response and are resistant to oral candidiasis ( 24 ). Be-
cause IL-12p40 is a common component of IL-12 and IL-23, 
we hypothesized that a Th17-mediated response rather than 
a defective Th1 response is responsible for the increased sus-
ceptibility of the IL-12p40 KO mice to OPC. 
 To dissect host responses to OPC systematically, we used 
a model of OPC ( 25 ) using mice defi cient in Th1 cells (IL-
12p35 KO ), Th17 cells (IL-23p19 KO ), IL-17RA (the receptor 
for IL-17 and IL-17F), or IL-22. Here, we show that IL-
17RA KO and IL-23 KO mice are profoundly susceptible to oral 
candidiasis, whereas IL-12 KO mice show only a slight increase 
in fungal burden and no overt fungal lesions. Analyses of the 
oral mucosa revealed induction of IL-17 target genes encod-
ing neutrophil-activating factors, CXC-chemokines, and 
antimicrobial proteins in WT mice after oral  C. albicans 
infection. The majority of these genes were suppressed in IL-
17RA KO mice after infection, particularly   defensin 3 (BD3). 
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infi ltration of the infected area with PMNs was observed. 
However, the degree of neutrophilic infi ltrate was signifi -
cantly reduced compared with WT or IL-12  KO  mice, and PMNs 
appeared to be clustered in  “ nests ” rather than crossing into 
were found in the IL-12 KO mice ( Fig. 2 F ). Hyphal formation 
and invasion of the superfi cial epithelial layer were visible 
in IL-23 KO tongue sections, confi rming invasive candidiasis 
( Fig. 2 D ). Disruption of the superfi cial epithelium and some 
 Figure 1.  Model of murine OPC. (A) Timeline of infection model. (B) WT mice are resistant to OPC unless they are immunosuppressed. WT mice ( n = 8) 
or WT mice treated with cortisone acetate ( n = 16) were infected sublingually with  C. albicans , and after 5 d CFU/g of tongue tissue was assessed in tripli-
cate (log scale). These data are from at six independent experiments. (C – E) Histological evaluation of  C. albicans  infection. At day 5, sections of tongue 
from the indicated mice were stained with PAS to visualize  C. albicans (Ca) or hematoxylin and eosin (H & E; which does not stain fungi) and viewed at 10X 
or 40X magnifi cation. Fungal lesions, papillae, and keratinized layer are indicated. (C) WT mice subjected to sham infection. (D) WT mice without cortisone 
were infected orally with  C. albicans . (E) WT mice treated with cortisone acetate were infected orally with  C. albicans . TB, taste bud; BV, blood vessel; BL, 
basal layer; ker, keratinized layer; Neu, neutrophil; Eo, eosinophils; Ca,  C. albicans. Data are representative of 2 – 3 mice per strain. Bars, 100   m. (F) OPC 
induces weight loss in cortisone-treated WT mice. All mice were weighed daily, and weight (gram) on each day of infection is indicated. *, P  < 0.05. Circles, 
Sham-infected mice; squares,  C. albicans – infected mice. (G) OPC on day 5 after inoculation with  C. albicans . Fungal lesions on tongue of WT mice treated 
with cortisone acetate. 
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the IL-12 KO mice, and  C. albicans cells were almost never 
found on the surface or invading epithelial tissue ( Fig. 2 C 
and not depicted). A prominent neutrophilic infi ltrate oc-
curred both in the muscular area and the subepithelial layer, 
the infected areas ( Fig. 2, D and E ). Fungal invasion in the 
IL-23 KO mice was less profound than in cortisone-treated 
mice ( Fig. 1 E vs.  Fig. 2 D ). In contrast to IL-23 KO or cortisone-
treated mice, there was little damage to the epithelial layer in 
 Figure 2.  Th17-defi cient mice are more susceptible to OPC than Th1-defi cient mice . (A) Quantitation of  C. albicans infection in Th1-defi cient 
(IL-12 KO ) and Th17-defi cient (IL-23 KO ) mouse strains. IL-12 KO mice ( n = 13) and IL-23 KO mice ( n = 9) were infected orally with  C. albicans and CFU/gram 
tongue tissue was assessed. Each dot represents an individual mouse, and horizontal bar indicates the geometric mean, which is also indicated below. 
*, P  < 0.05 by Mann-Whitney  t test. Note, the WT mouse data are the same as that shown in  Fig. 1 B . IL-12 KO mice were evaluated in three independent 
experiments, and IL-23 KO mice were evaluated in two independent experiments. (B) OPC-induced weight loss in Th1-defi cient or Th17-defi cient strains. 
Mice were weighed daily and percentage of weight change compared with day 0 is shown for each strain. *, P  < 0.05. Triangles, Sham-infected mice; 
squares,  C. albicans – infected mice. (C and D) Histological evaluation of  C. albicans infection in IL-12 KO versus IL-23 KO mice. At day 5, sections of tongue 
from the indicated mice were stained with PAS or hematoxylin and eosin (H & E) and viewed at 10 – 40X magnifi cation. Data are representative of two 
mice per strain. Bars, 100   m. (E) Quantitation of histological evaluation of PMNs. Six sections per mouse from two mice per group were evaluated for 
the number of PMNs per microscopic fi eld, either in the vicinity of fungal lesions or parallel to areas of sham-infected tongue. Evaluators were blinded 
to the identity of the samples. (F) OPC on day 5 after inoculation with  C. albicans . Fungal lesions on tongues of representative IL-12 KO or IL-23 KO mice 
are shown. 
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(which must be killed by day 5 for humane reasons), OPC 
cannot be resolved in the absence of IL-17RA signaling. In 
contrast, IL-12 and hence Th1 cells are not essential for host 
defense against oral candidiasis, although they do contribute 
to some extent to limiting infection. 
 In an attempt to determine whether IL-17 is suffi  cient to 
rescue the Th17 defi ciency, we added IL-17 orally twice 
daily to IL-23 KO mice throughout a 5-d course of infection 
(unpublished data). However, ectopic application of IL-17 
led to a systemic reaction characterized by reddening of the 
skin in the face and chest, and IL-17 – treated mice were no-
ticeably sicker than controls. There was no statistically signif-
icant diff erence in oral fungal burden between the groups 
(unpublished data). Accordingly, the confounding systemic 
eff ects of IL-17 may have counteracted any benefi cial eff ects 
in the oral cavity. 
 Th17 cells also produce IL-22, which has been shown to 
play a more vital role than IL-17 in host defense against cer-
tain gut and lung mucosal pathogens ( 27, 28 ). Therefore, we 
evaluated the eff ect of an IL-22-defi ciency in OPC. How-
ever, IL-22 KO mice showed only a mild susceptibility to OPC 
compared with IL-17RA KO mice, although they lost weight 
after infection ( Fig. 3, A and B ). Consistent with their ability 
to largely combat fungal infections, IL-22 KO mice showed 
robust neutrophilic infi ltrates into the infected lesion sites 
( Fig. 3 D ). There was no evidence of overt fungal lesions on 
the tongue, either visually (not depicted) or histologically 
( Fig. 3 D ). Therefore, in contrast to lung and gut, IL-17 sig-
naling appears to play a more important role in mediating 
immunity to infection in the oral cavity than IL-22 (see 
Discussion). 
   -TCR and CD8 + cells, and not    -TCR cells or IL-22, 
contribute to immunity to OPC 
 IL-17 is produced by CD4 + and CD8 + cells that express 
the    -TCR, and also by an innate population of    -TCR 
T cells in an IL-23 – dependent manner ( 29 ). In  Escherichia 
coli ,  Mycobacterium tuberculosis , and  Klebsiella pneumonia set-
tings, the    -T cell population appears to be the dominant 
IL-17 – producing T cell subset involved in host defense ( 30, 31 ). 
To determine which subset was primarily responsible for 
immunity against OPC,    -T cell – defi cient mice or    -T 
cell – defi cient mice were infected with  C. albicans . Low lev-
els of infection were observed in    -TCR KO mice, whereas 
substantial infection occurred in    -TCR KO mice ( Fig. 4 A ). 
These data are consistent with the sensitivity of HIV + indi-
viduals to OPC ( 3 ) and the fi nding that PBMCs from healthy 
human donors contain  C. albicans – specifi c memory CD4 + 
Th17 cells ( 11, 20 ). CD8 + T cells and innate CD8 + NKT 
cells also secrete IL-17 ( 32, 33 ), and CD8 KO mice showed a 
similar susceptibility to OPC as the    -TCR KO mice ( Fig. 4 A ). 
Interestingly, the fungal burden in    -TCR KO mice was repro-
ducibly lower than the IL-17RA KO or IL-23 KO mice ( Fig. 4 A 
vs.  Fig. 2 A and  Fig. 3 A ). Consistent with this observation, 
the    -TCR KO mice did not lose as much weight as IL-23 KO 
or IL-17RA KO mice ( Fig. 4 B vs.  Fig. 2 B and  Fig. 3 B ). 
indicative of an ongoing immune response ( Fig. 2, C and E ). 
Thus, IL-23, but not IL-12, is required to prevent invasive 
oral candidiasis and permit a robust PMN response. 
 IL-23 drives expansion of the Th17 lineage, and IL-17 
and IL-17F are hallmark Th17 cytokines that bind to a com-
mon receptor, IL-17RA. The oral fungal burden (2.64  × 10 4 
CFU/g;  Fig. 3 A ) and weight loss ( Fig. 3 B ) in IL-17RA KO 
mice were not statistically diff erent from the IL-23 KO mice 
and were higher than the IL-12 KO mice (compare  Fig. 3 to 
 Fig. 2 ; statistical comparisons not depicted). Fungal lesions 
were visible on the tongue and palate at levels similar to the 
IL-23 KO mice (not depicted), and invading hyphae were fre-
quently found in IL-17RA KO tongue sections ( Fig. 3 D ). De-
struction of the epithelial and basal layers was observed in 
IL-17RA KO sections, similar to the IL-23 KO mice. Some 
neutrophilic infi ltrates were present, similar to the IL-23 KO 
mice, but were less numerous than in IL-12 KO or WT tissue 
( Fig. 3 D ). In IL-17RA KO mice, as in IL-23 KO mice, PMNs 
appeared to be trapped in  “ nests, ” and there was no evidence 
of  C. albicans phagocytosis as there was in the WT mice 
(compare with  Fig. 1 D ). Thus, IL-17 receptor signaling ap-
pears to account for much if not all of the IL-23 – mediated 
protection, which is apparently caused in part by a failure to 
recruit PMNs into infected tissue. 
 We next assessed IL-17 expression in T cells from the 
draining cervical LN (cLN) after infection. Cortisone acetate 
treatment results in reduced lymphocyte numbers, so it was 
not surprising that WT mice treated with corticosteroids had 
extremely small cLNs, and not enough viable lymphocytes 
could be recovered to assess cytokine expression (unpub-
lished data). However, IL-17RA KO mice (which can produce 
IL-17, but not respond to it) showed signifi cantly increased 
numbers of IL-17 + T cells after infection compared with un-
infected mice ( Fig. 3 C ). Even without additional stimulation 
of the TCR,   1% of the cLN lymphocytes stained positive 
for IL-17, comparable to reports with  Toxoplasma gondii in-
fection ( 26 ). After 2 d of in vitro restimulation of the TCR, 
  12% of T cells expressed IL-17, compared with  < 1% in 
sham-treated mice. Thus, IL-17 – producing cells are activated 
after oral  C. albicans infection. Moreover, sham-treated mice 
do not harbor substantial numbers of IL-17 – expressing T 
cells before infection. 
 Next, we questioned whether IL-17RA KO mice could 
eventually clear  C. albicans , or whether IL-17 signaling was 
necessary to recover from OPC. Accordingly, IL-17RA KO 
mice were monitored for weight loss and signs of infection 
for 2.5 wk ( Fig. 3 G ). Whereas WT mice showed almost no 
fungal burden 5 d after inoculation and fully recovered their 
body weight ( Fig. 1 F ), IL-17RA KO mice lost weight ( Fig. 3 H ) 
and maintained a mean fungal burden of 6.8  × 10 5 CFU/g 
 C. albicans throughout a 17-d time course. In contrast, IL-
12 KO mice showed an early spike in fungal burden in the 
tongue, but fungal clearance and weight recovery were evi-
dent by the end of the experiment ( Fig. 3, G and H ). These 
data indicate that, whereas the oral fungal burden of the IL-
17RA KO mice was lower than WT mice treated with steroids 
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 Figure 3.  IL-17 signaling is essential for host defense against OPC. (A) IL-17RA KO mice are sensitive to OPC. The indicated mouse strains (IL-
17RA KO ,  n = 8; IL-22 KO ,  n = 7) were infected with  C. albicans and CFU/g tongue was assessed by colony enumeration. *, P  < 0.05. Geometric mean is indi-
cated by horizontal bars and below. Note, data from WT mice are the same as shown in  Fig. 1 B . IL-17RA KO mice data are representative of three 
independent experiments, and IL-22 KO data were from one experiment. (B) OPC-induced weight loss in susceptible strains. Percentage of weight change 
compared with day 0 is shown. (C) IL-17 + cells are induced after  C. albicans infection. Cells were isolated from the draining cervical lymph nodes of in-
fected IL-17RA KO mice. Cells were incubated  ± anti-CD3 + anti-CD28 for 48 h, and percentage of cells staining positive for IL-17 was assessed by intracel-
lular fl ow cytometry. **, P  < 0.01. n.s. not statistically signifi cant. (D and E) Histological evaluation of  C. albicans infection in IL-17RA KO or IL-22 KO mice. At 
day 5, sections of tongue from the indicated mice were stained with PAS or H & E and viewed at 10X-40X magnifi cation. Data are representative of two 
mice per strain. Scale bars indicate 100 microns. (F) Quantitation of histological evaluation of PMNs. Six sections per mouse from 2 mice per group were 
evaluated for the number of PMNs per microscopic fi eld, either in the vicinity of fungal lesions or parallel areas of sham-infected tongue. Evaluators were 
blinded to the identity of the samples. * P  < 0.05. (G) IL-12 KO but not IL-17RA KO mice can recover from oral  C. albicans infection. WT ( n = 4), IL-17RA KO 
( n = 12) and IL-12  KO  ( n = 12) mice were infected with  C. albicans . On the indicated days (ranging from 1 – 17), 1 – 3 mice per group were killed and  C. albicans 
CFU per gram of tongue was evaluated by colony enumeration. Geometric mean for each day is shown. Time course data are from one experiment. 
(H) Weight loss correlates with degree of OPC susceptibility. Weight changes in IL-12 KO and IL-17RA KO mice over time are shown. 
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ing decrease in neutrophilic infi ltrate observed in IL-23 KO 
and IL-17RA KO mice compared with WT mice ( Fig. 2 ). 
 In IL-17RA KO mice compared with WT, there was a no-
table diminution in genes encoding antimicrobial proteins that 
are known to exert candidacidal activity, including BD3 
(DEFB3; 6-fold) and CCL20 (2.4-fold;  Fig. 5 B ) ( 37, 38 ). In-
deed, BD3 was the most diff erentially expressed gene between 
WT and IL-17RA KO mice based on the microarray analysis 
( Fig. 5 B ). Diff erential expression of BD3 and CCL20 mRNA 
between WT and IL-17RA KO mice was verifi ed by real-time 
RT-PCR ( Fig. 5 H and Fig. 6 A ). CCL20 and BD3 have both 
been reported to have direct killing activity against  C. albicans 
 ( 38 ). We verifi ed that BD3 could indeed kill  C. albicans cells in 
vitro comparable to physiological concentrations (7  μ M) of a 
human salivary anticandidal peptide histatin-5 ( 37 ), but there 
was no detectable killing activity by recombinant CCL20, 
even at high concentrations (25  μ M;  Fig. 6 C ). 
 Saliva contains potent antimicrobial factors, and patients 
with salivary gland defects caused by radiation or Sjogren ’ s 
syndrome are highly susceptible to OPC ( 39, 40 ). Almost no 
biochemical characterization of murine saliva has been re-
ported. As shown in  Fig. 6 (A and B) , WT mice express in-
creased levels of BD3 mRNA and protein in tongue after  C. 
albicans infection, which are markedly reduced in IL-17RA KO 
mice. Next, we evaluated the ability of saliva from various 
KO mouse strains to kill  C. albicans cells in vitro ( Fig. 6, C 
and D ). As a positive control for candidacidal activity, we 
verifi ed that the human salivary peptide histatin-5 at a con-
centration of 7  μ M killed   22% of  C. albicans , as previously 
reported ( 41 ) ( Fig. 6, C and D ). WT murine saliva was col-
lected after carbachol injection and incubated with  C. albicans 
cells in vitro, and yeast survival was determined by plating 
This is unlikely because of subtle strain diff erences, as we 
observed no quantitative or qualitative diff erences in suscep-
tibility to OPC between BALB/c and C57BL/6 (Fig. S1, 
available at http://www.jem.org/cgi/content/full/jem
.20081463/DC1). Instead, IL-17 from another source such 
as NKT cells ( 32, 33 ) or neutrophils ( 29 ) may contribute to 
defense against OPC. 
 Downstream effects of IL-17RA signaling on saliva and oral 
mucosal tissue 
 To defi ne mechanisms by which IL-17 mediates anti – C. al-
bicans host defenses in the oral mucosa, we performed gene 
profi ling analysis of tongue mRNA from WT or IL-17RA KO 
mice at baseline (uninfected,  “ Day 0 ” ) or 24 h after infection 
( “ Day 1 ” ). Although WT mice showed no evidence of OPC 
5 d after inoculation with  C. albicans ( Fig. 1 ), many immune 
genes were induced in WT oral mucosa after 24 h of expo-
sure to  C. albicans . Highly represented were  “ Th17 signa-
ture ” genes, i.e., genes associated with Th17 function or 
known targets of Th17 hallmark cytokines ( 10, 34 ) ( Fig. 5 A ; 
see also Fig. S3). Among the most strongly induced genes 
were S100A8 and S100A9 (237- and 220-fold, respectively), 
CXCL2 (234-fold), CXCL5 (164-fold), LCN2/24p3 (lipo-
calin 2; 94-fold), IL-6 (41-fold), MMP8 (23-fold), CCL20 
(29.5-fold), CSF3 (G-CSF, 17.8-fold), NF-  Biz (NF-  B  ; 
12.3-fold), IL-22 (7-fold), and DEFB3 (BD3; 5.3-fold). All 
are known targets of IL-17 signal transduction, either alone 
or in combination with TNF-  or IL-22. Interestingly, sev-
eral C-type lectin receptors were up-regulated that have been 
associated with  C. albicans responses, including Clec4e (Min-
cle; 97.3-fold), Clec4n (Dectin-2; 11.9-fold), and Clec7a 
(Dectin-1; 9.2-fold) ( 35 ,  36 ) ( Fig. 5 A ). In contrast, few Th1- 
or Th2-related genes were up-regulated (see also Fig. S3). 
Quantitative real-time PCR experiments demonstrated that 
IL-17 was enhanced by approximately threefold in WT mice 
after  C. albicans infection ( Fig. 5 C ). IL-22 was also up-regu-
lated in the microarray and in real-time RT-PCR ( Fig. 5 D ). 
Messenger RNA encoding the Th1 cytokines IFN-  and IL-
12 were induced as well ( Fig. 5, E and F ), consistent with the 
fact that Th1-defi cient (IL-12 KO ) mice show an increased 
fungal burden, although no fungal lesions are manifest and 
almost no hyphal yeast cells are found invading the oral cavity 
in the IL-12 KO mice ( Fig. 2 C ). 
 In IL-17RA KO mice, up-regulation of Th17 profi le genes 
was considerably lower than in WT ( Fig. 5 A , white bars 
vs. red bars; and Figs. S4 – S6), although many were still in-
duced to some extent, presumably via the activity of other 
remaining infl ammatory cytokines. IL-17 was also constitu-
tively elevated in IL-17RA KO mice, which has been previ-
ously reported ( 8 ), as were IL-22, IFN-  , and IL-12 ( Fig. 5, 
D and F ). When comparing diff erentially expressed genes 
in WT versus IL-17RA KO mice 24 h after infection, there 
was a reduction in many genes associated with neutrophil 
recruitment such as CXCL1, CXCL5 (both 3.1-fold), and 
CSF3/G-CSF (3.3-fold;  Fig. 5 B ), consistent with the strik-
 Figure 4.  Host defense against oral  C. albicans is mediated mainly 
by    -T cells, rather than    -T cells. Mice defi cient in    -T cells ( n = 
14),    -T cells ( n = 13), or CD8 ( n = 8) were inoculated with  C. albicans 
and fungal burden (CFU/g tissue) in tongue (A) and daily weight (B) were 
assessed. CD8 KO mice were evaluated in one experiment, and the    KO and 
   KO mice were evaluated in three independent experiments. 
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inoculation ( Fig. 6 D ). Therefore, IL-23 and IL-17, but not 
IL-12, regulate the antimicrobial activity of mammalian saliva. 
 To determine whether IL-17 stimulates anticandidal ac-
tivity on cells that form nonimmune tissue, we stimulated 
a murine stromal cell line with IL-17 and/or TNF-  and 
assessed conditioned media (CM) for eff ects on  C. albicans . 
CM from cells treated with IL-17 or TNF-  alone did not 
trigger candidacidal activity, but CM from cells treated with 
both IL-17 and TNF-  killed   30% of yeast in this assay, 
indicating that these cytokines stimulate secretion of factors 
and colony enumeration. Saliva from WT mice killed a mean 
of 14.5% of  C. albicans cells, and was not statistically diff erent 
from saliva derived from IL-17RA – defi cient mice ( Fig. 6 D ). 
However, saliva from IL-23 KO mice reproducibly showed 
signifi cantly reduced fungicidal activity (approximately three-
fold). 24 h after oral inoculation with  C. albicans , saliva from 
both IL-23 KO and IL-17RA KO mice exhibited reduced can-
didacidal activity compared with WT saliva. In contrast, saliva 
from IL-12 KO mice consistently showed elevated candidacidal 
eff ect compared with WT, both at baseline and 24 h after 
 Figure 5.  Mechanism of IL-17 – mediated host defense against OPC.  (A) Oral inoculation with  C. albicans induces Th17 signature genes in oral 
mucosal tissue, which are suppressed in IL-17RA KO mice. Tongue tissue from female WT or IL-17RA KO mice ( n = 2, from independent experiments) was 
taken at baseline (day 0) or 24 h after oral  C. albicans inoculation (day 1), and cDNA was prepared and hybridized to Affymetrix genechips. Shown are 
Th17-related genes found to be induced on day 1 compared with day 0 from WT mice (red bars) or IL-17RA KO mice (white bars). (B) Differentially ex-
pressed genes in WT versus IL-17RA KO mice determined by microarray analysis. Fold change of genes induced in WT mouse tongue compared with IL-
17RA KO tongue on day 1 are indicated. * indicates genes previously connected to IL-17 or Th17 cells. (C – J) OPC-induced expression of selected genes. 
Tongue mRNA from WT or IL-17RA KO mice on day 0 or day 1 (mRNA from two mice from independent experiments) was subjected to quantitative real-
time RT-PCR analysis in triplicate. Data are presented as fold induction, normalized to GAPDH. *, P  < 0.05 compared with WT Day 0;  ‡ , P  < 0.05 compared 
with IL-17RA KO Day 0. 
JEM VOL. 206, February 16, 2009 
ARTICLE
307
seminated form of disease ( 42 ). To determine whether Th1 
or Th17 cells contribute to this immune barrier, we evalu-
ated  C. albicans CFU in kidney. Surprisingly, IL-12 KO mice, 
but not IL-23 KO or IL-17RA KO mice, showed some evidence 
of kidney infection ( Fig. 7 ). Consistently, mice lacking    -
TCR cells (which lack Th1 cells and other Th subsets) 
showed evidence of systemic infection, although CFUs were 
not high enough to cause lethality. Nonetheless, these data 
suggest that Th1 cells, although relatively less important for 
host defense against OPC compared with Th17 cells, may be 
an important component of fungal immunity by helping to 
limit spread beyond the oral cavity. Still, because the fungal 
burden was sublethal and AIDS patients with low CD4 + T 
cell counts do not generally contract disseminated candidiasis, 
additional components evidently contribute to controlling 
dissemination of  C. albicans . 
 DISCUSSION 
 OPC is a debilitating disease of immunodefi ciency, charac-
terized by fungal lesions on the palate, oropharynx, tongue, 
and buccal mucosa. Disease can progress to esophageal candi-
diasis, and limit nutritional intake and threaten overall health. 
OPC is the most frequent opportunistic fungal infection 
among HIV + individuals not receiving eff ective antiretroviral 
therapy ( 14 ), and it is also a problem in cancer patients on 
chemotherapy ( 43 ). Candidiasis occurs in 35% of Sjogren ’ s 
syndrome patients ( 40 ), and the elderly, infants, and denture 
wearers are also at risk ( 2 ). 
 An intriguing feature of host defense against  C. albicans is 
the anatomical compartmentalization associated with disease. 
For example, HIV + individuals experience OPC but do not 
show enhanced incidence of vaginal or disseminated candidi-
asis ( 3 ). Immunity to OPC involves antifungal salivary proteins, 
PMNs, CD8 + cells and nonimmune cells such as oral kerati-
nocytes, stromal cells, and epithelial cells ( 2, 14 ). Interactions 
with antimicrobial activity (Fig. S2, available at http://www
.jem.org/cgi/content/full/jem.20081463/DC1). Thus, in an 
infl ammatory environment, IL-17 contributes to an antifun-
gal state in cooperation with other infl ammatory cytokines. 
 Th1 cells, but not Th17 cells, help limit breaching 
of the oral mucosal barrier 
 OPC generally remains contained in the oral cavity, and is 
not thought to breach this mucosal barrier to establish a dis-
 Figure 6.  Anticandidal factors and Th17 defi ciency. (A) IL-17RA KO 
mice show decreased expression of mBD3 mRNA. Quantitative real-time RT-
PCR analysis was performed in triplicate on tongue cDNA from WT or IL-
17RA KO mice ( n = 2 – 4) at baseline (day 0) or day 1 or 5 after  C. albicans 
infection. *, P  < 0.05 compared with Day 0;  ‡ , P  < 0.05 compared with WT 
sample at Day 5. (B) IL-17RA KO mice show decreased expression of mBD3 
protein. Tongue tissue from WT mice or IL-17RA KO mice at day 0 or 5 ( n = 4 
for each condition) were applied to nitrocellulose in slot blots and probed 
with antibodies to mBD3. Signals were quantifi ed by densitometry. *, P  < 
0.05. ns = not signifi cant. Sample slot blot samples are shown below (note: 
all were taken from the same fi lm at the same exposure level). (C) Candida-
cidal activity of BD3 and CCL20. Recombinant BD3 (0.1, 0.5 or 25  μ M) and 
CCL20 (25  μ M) were evaluated for fungicidal activity by incubation with 10 6 
 C. albicans cells for 1.5 h in triplicate. Human histatin-5 (7  μ M) was used as 
a positive control ( 37 ). Yeast were diluted and spread on YPD agar for colony 
enumeration. Data were compared by unpaired Student’s  t test (*, P  < 0.05 
compared with WT controls). Data are representative of three independent 
experiments. (D) Reduced candidacidal activity in IL-17RA-defi cient and 
Th17-defi cient (IL-23 KO ) saliva. Saliva was collected from the indicated mice 
( n = 3 – 6) after carbachol injection and assayed for candidacidal activity in 
triplicate as in B. Experiments were performed twice with similar results. 
 Figure 7.  IL-12, but not IL-23 or IL-17RA, limit dissemination of 
 C. albicans from the oral cavity . The indicated KO mice (   -T KO ,  n = 13; 
   -T KO ,  n = 14; IL-12 KO ,  n = 14; IL-23 KO ,  n = 4; IL-17RA KO ,  n = 9) were 
infected orally with  C. albicans as in  Fig. 1 , and kidneys were isolated on 
day of sacrifi ce. After homogenization, CFU/gram kidney was determined 
by colony enumeration in triplicate. Data were collected from all experi-
ments in Figs. 2–4. 
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 Saliva plays a vital defensive role in the oral cavity ( 14 ). 
Saliva from IL-17RA KO and IL-23 KO is defective in killing  C. 
albicans ( Fig. 6 D ), which may be at least partly caused by a de-
fi ciency in antimicrobial substances ( Fig. 5 ). BDs are produced 
by salivary glands but also by epithelial cells in the gingiva, 
buccal mucosa, and tongue ( 54 ), and they exert anticandidal 
activity in vitro ( Fig. 6; Fig. 5 B ; and Fig. S3, available at 
http://www.jem.org/cgi/content/full/jem.20081463/DC1) 
( 37, 55 ). IL-17 regulates BD3 in lung cells in humans and 
mice ( 56 ). Here, we show that BD3 mRNA and protein are 
up-regulated in WT mice after infection with  C. albicans , and 
there was an impairment in BD3 expression in IL-17RA KO 
tongue compared with WT mice ( Fig. 5 B; Fig. 6, A and B ; 
and Figs. S3 – S6). In contrast to tongue, there was little dif-
ference in BD3 levels in saliva between WT and IL-17RA KO 
mice (unpublished data). Thus, although the basis for the re-
duced salivary fungicidal activity in IL-23 KO and IL-17RA KO 
remains unclear, BD3 likely contributes to the reduced infec-
tion on the oral mucosal surface. 
 Antimicrobial peptides also function as chemotactic fac-
tors for immune cells. BD2 recruits dendritic cells and T cells 
via CCR6 ( 57 ), and S100A8/A9 are chemotactic for neutro-
phils ( 58 ). Another ligand for CCR6 is CCL20, which was 
impaired in IL-17RA KO mice after infection ( Fig. 5 H ). Like 
BDs, CCL20 has chemotactic activity for T cells and DCs. 
CCL20 is regulated by IL-17 ( 59, 60 ), is expressed by Th17 
cells ( 61 ) and has been linked to Th17 recruitment to in-
fl amed sites ( 13 ). Although CCL20 has been reported to ex-
ert antimicrobial activity against  C. albicans  in vitro ( 38 ), we 
did not observe this eff ect, perhaps because of diff erences in 
the commercial preparations of the chemokine or the specifi c 
strain of  C. albicans used ( Fig. 6 C ). 
 Our fi ndings are similar to, yet distinct from, observations 
made regarding Th17 function at other mucosal sites. A mi-
croarray study of  K. pneumonia – infected lung found many of 
the same genes, including BDs, CXC chemokines, lipocalin 
2, and IL-6, although BD3 was not identifi ed in that study 
( 27 ). Microarray studies in RA synoviocytes ( 60 ) and after 
 Salmonella enterica serovar Typhimurium infection in ma-
caques ( 9 ) found similar IL-17 target genes induced during 
disease states. The  K. pneumonia study reported that IL-22, 
another Th17 cytokine, is a critical host-protective cytokine 
( 27 ), but our data suggest that IL-22 is less important than 
IL-17 in the oral cavity ( Fig. 3 A ). Humans with mutations 
in STAT3 (hyper-IgE syndrome [HIES]) fail to develop 
Th17 cells and experience recurrent oral and mucocutaneous 
 C. albicans infections. One study indicated that HIES patients 
show normal levels of IL-22 in the CD4 + T cell population 
( 20 ). Conversely, several other studies report reduced IL-22 
levels in HIES patients ( 62 – 64 ). Because IL-17 and IL-22 
cooperatively regulate chemokines and antimicrobial genes 
( 65 ), we cannot rule out a role for IL-22 in contributing to 
host defense to OPC, particularly in humans. 
 Intriguingly, IL-12, and hence Th1 cells, may help limit 
transition to a disseminated form of candidiasis, as IL-12 KO but 
not IL-23 KO or IL-17RA KO exhibited detectable  C. albicans 
between PMNs and T cells are required for maintaining host 
defense to OPC ( 2, 44 ). Th17 cells link CD4 cells and the 
PMN response by IL-17 – mediated regulation of neutrophil 
expansion, recruitment, and migration ( 15, 29 ), and provide 
a satisfying explanation for why CD4 + T cells are so impor-
tant in OPC. Consistently, we observed a large neutrophilic 
infi ltrate in resistant mice (WT, IL-12 KO , and IL-22 KO ) after 
 C. albicans inoculation, which was greatly diminished in sus-
ceptible (IL-23 KO and IL-17RA KO ) mice ( Figs. 2 and 3 ). 
 Gene-targeted mice permit hypothesis-driven studies to 
defi ne immune components involved in candidiasis. Huang 
et al. ( 17 ) identifi ed a protective role for IL-17 in dissemi-
nated candidiasis, as IL-17RA KO mice are susceptible to sys-
temic disease caused by defects in neutrophil migration and 
chemokine expression. Dectin-1 KO mice show defective de-
velopment of Th17 cells ( 18, 19 ) and are susceptible to dis-
seminated candidiasis, although this fi nding has been 
controversial ( 19, 45 ). Conversely, IL-23 and IL-17 drive in-
fl ammatory pathology in models of pulmonary aspergillosis 
and gastric candidiasis ( 22 ), and IL-17 neutralization unex-
pectedly protects from disseminated candidiasis in a study by 
this group ( 46 ). Although the relevance of the gastric candi-
diasis model to human disease is questionable, Th17 cells me-
diate pathology in airway disease, rheumatoid arthritis, and 
EAE ( 47, 48 ). Recent studies support the notion that the 
Th17 pathway, rather than the Th1 pathway, drives defense 
to OPC. IFN-  KO and IL-4 KO mice are resistant to OPC, 
whereas IL-12p40 KO mice are susceptible ( 24 ). Here, we 
demonstrate that IL-23 and IL-17RA are required for eff ec-
tive resistance to OPC, whereas IL-12 and IL-22 play less 
critical roles ( Figs. 2 and 3 ). The propensity of proinfl amma-
tory cytokines to play opposing roles in disease is well docu-
mented ( 49 ), and IL-17 appears to be no exception. For 
example, in the oral cavity, the role of IL-17 in periodontal 
disease may be host-protective or destructive depending on 
disease severity and chronicity ( 15, 50 ). 
 Our data indicate that    -T cells, although a major source 
of IL-17 ( 29 ), are less important than    -T cells in prevent-
ing OPC ( Fig. 4 ). This was surprising, given the rapid time 
course of disease (5 days). However, only 2% of T cells in the 
oral epithelium are    -T cells ( 51 ), and these cells apparently 
do not play a defensive role in vaginal candidiasis ( 52 ).    -T 
cells also produce IL-22, which we fi nd to play a relatively 
less important role in OPC ( Fig. 3 A ). On the other hand, 
   -T cells have been suggested to enhance resistance to gas-
tric candidiasis ( 53 ). We have noticed that some    -T cell –
 defi cient mice experienced higher levels of  C. albicans CFU 
when experiencing stress (e.g., poor recovery from anesthesia 
or the presence of a dead mouse in the cage; unpublished 
data). Although mice were eliminated from the study when 
such confounding factors were obvious, this may explain 
why a subset of    -T cell – defi cient mice showed detectable 
 C. albicans colonization ( Fig. 4 ). Unidentifi ed environmental 
stressors may have predisposed certain    -TCR KO mice to 
OPC, and thus the    T cell subset may provide an addi-
tional layer of protection against candidiasis. 
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performed as previously described ( 41 ). For saliva testing, 90   l of freshly 
collected murine saliva was incubated with 10 4 cells of  C. albicans for 1 h at 
37 ° C, plated in triplicate, and assayed for colony enumeration. BD3 and cy-
tokines were from R & D Systems. 
 Cell culture, fl ow cytometry, and histology.  ST2 cells were stimulated 
with 100 ng/ml IL-17 or 2 ng/ml TNF-  for 24 h in   -MEM media sup-
plemented with 10% FCS. Cytokines and defensins were obtained from 
R & D Systems. For FACS, cLNs were harvested at day of sacrifi ce and cells 
stimulated with   -CD3 and   -CD28 antibodies (BD) for 48 h. Samples 
were stained intracellularly with anti – IL-17-PE antibodies (BD) and ana-
lyzed on a FACSCalibur with CellQuest software. Paraffi  n-embedded sam-
ples were stained with hematoxylin and eosin or periodic-acid Shiff  (PAS) by 
the University at Buff alo Histology Core. Sections were analyzed at 10 – 40X 
magnifi cation, and all scale bars indicate 100   m. 
 Microarray and real-time RT-PCR.  Whole tongues from WT or IL-
17RA KO female mice, age 10 – 16 wk ( n = 2, age-matched within infection 
pairs), were harvested at baseline or 24 h after  C. albicans inoculation and 
preserved in RNALater (Ambion). Total mRNA and cDNA were prepared 
and hybridized on Aff ymetrix Mouse 430 – 2 Genechips. Preparation and 
analysis were performed by the Roswell Park Cancer Institute Gene Expres-
sion Resource Facility (Buff alo, NY) using the Partek Genomics Suite 6.4 
(RMA algorithm) with a quantile normalization and probe set summariza-
tion at median Pol. Real-time RT-PCR was performed on tongue samples 
in triplicate using SYBR Green and normalizing to GAPDH as previously 
described ( 75 ). Primers were purchased from SuperArray. 
 BD slot blot.  Tongues from indicated mice were homogenized in lysis 
buff er (10 mM NaPB, 1 mM EDTA, 1  μ g/ml aprotinin, leupeptin, pep-
statin-A, 1 mM PMSF, and 0.1% SDS), centrifuged to remove debris, and 
quantifi ed for protein content. A 1.2-  μ g sample was loaded per slot blot well 
onto nitrocellulose, and blots were probed with 1  μ g/ml anti-BD3 antibod-
ies (Santa Cruz Biotechnology). Blots were quantifi ed by scanning densi-
tometry on an HP Scanjet 3970 and analyzed with Quantity One software 
(BioRad Laboratories). 
 Statistics.  At least two biological replicates were performed for all experi-
ments unless otherwise indicated. Data were compared by Mann-Whitney 
or unpaired Student ’ s  t test using GraphPad Prism (v. 4) or Microsoft Excel 
software. P values  < 0.05 were considered signifi cant. 
 Online supplemental material.  Fig. S1 shows that similar levels of  C. al-
bicans infection are found in IL-17RA – defi cient mice on the C57BL/6 
background compared with the BALB/c background. Fig. S2 shows that 
IL-17 and TNF-  stimulation of a murine bone marrow stromal cell line 
(ST2) triggers secretion of factors with signifi cant candidacidal activity. Figs. 
S3 – S6 show primary microarray data comparing gene expression in tongue 
tissue of female WT and IL-17RA KO mice either at baseline or 24 h after 
 C. albicans inoculation. Online supplemental material is available at http://
www.jem.org/cgi/content/full/jem.20081463/DC1. 
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infection in kidney ( Fig. 7 ). Although OPC causes consider-
able morbidity, disseminated candidiasis is associated with 
  40% mortality and is the fourth most common pathogen 
isolated from hospitalized patients ( 66 ). It is generally thought 
that disseminated candidiasis is initiated when  C. albicans en-
ters the bloodstream from the gut or indwelling catheters 
( 42, 67 ). This study is, to our knowledge, the fi rst to demon-
strate that oral disease can lead directly to systemic candidia-
sis, and moreover that Th1 cells are important in preventing 
a breach in the mucosal barrier. However, the kidney fungal 
burden in IL-12 KO mice was low, and thus other mechanisms 
contribute to eff ective barrier function. This contrasts a re-
cent study in the gut, which found that selective depletion of 
Th17 cells is seen after SIV infection in macaques, and thus 
promotes dissemination of  Salmonella ( 9, 68 ). Finally, IL-
12p35 was recently shown to be part of the cytokine IL-35 
produced by regulatory T cells ( 69 ), which could conceiv-
ably play a role in barrier function by limiting infl ammatory 
tissue damage during oral infection. Similarly, IL-17RA was 
recently reported to be a receptor subunit for the IL-25, 
which promotes Th2 cells ( 70 ). 
 Defi ning cytokines involved in immunity to OPC is im-
portant clinically, given increasing use of anticytokine bio-
logics. The role of the IL-23 and IL-17 in autoimmunity has 
stimulated development of blocking agents for these cyto-
kines ( 71 ). Although likely to prove useful in ameliorating 
infl ammatory pathology, consequences to opportunistic in-
fection need to be considered. Anti – TNF-  therapy predis-
poses to  M. tuberculosis infection, histoplasmosis, and fungal 
pneumonia, but thrush is only rarely seen ( 72 ). Consistently, 
TNF-  KO mice only show a mild increase in susceptibility to 
OPC ( 24 ), but are sensitive to disseminated candidiasis ( 73 ). 
Our data and fi ndings in HIES patients ( 20 ) suggest that com-
plete IL-17 and IL-23 blockade could increase OPC suscep-
tibility, but this will need to be evaluated in clinical settings. 
 In summary, immunity to  C. albicans depends on multiple 
immune components, as well as anatomical location. This 
study shows unequivocally that IL-17 and Th17 cells play a 
key role in protecting the host against OPC, whereas Th1 
cells and IL-22 play a relatively less important role. 
 MATERIALS AND METHODS 
 Mouse model of OPC.  IL-17RA KO mice were a gift from Amgen, and IL-
23p19 KO mice were provided by Genentech. IL-22 KO mice were produced 
in a collaboration between Genentech and Lexicon Pharmaceuticals to ana-
lyze the function of 500 secreted and transmembrane proteins ( 74 ). All other 
mice were purchased from The Jackson Laboratory. All mice were on the 
C57BL/6 background, and all were age and sex matched. Mice were caged 
individually after infection. If indicated, mice were treated with 225 mg/kg 
cortisone acetate (Sigma-Aldrich) and infected under anesthesia by placing a 
0.0025-g cotton ball saturated with 2  × 10 7 CFU  C. albicans (CAF2-1) sub-
lingually for 75 min, as previously described ( 25 ). No antibiotics were admin-
istered. Saliva was collected into chilled tubes after carbachol injection (100   l 
at 10 mg/ml) and used immediately in candidacidal assays. All protocols were 
approved by SUNY Buff alo Institutional Animal Care and Use Committee. 
 C. albicans culture and handling, candidacidal assays.  C. albicans was 
cultured in YPD by standard methods. Candidacidal assays were generally 
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